AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2010
Feb 3, 2010
33422_dirs_2010-02-03_ab8f0a26-72e9-4173-a6c6-da7d102df57f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRO PHARMACEUTICALS INC (PRW)
CIK: 0001133416
Period of Report: 2010-02-02
Reporting Person: FOLEY MAUREEN (Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-02-01 | Employee Stock Option (right to buy) | $.30 | A | 200000 | Acquired | 2015-02-01 | Common Stock (200000) | Direct |
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21